Clinical Conversations: GLP Practice Insights: GLP-1 Receptor Agonist’s Role in Mental Health and Substance Use Disorders (CE) episode artwork

EPISODE · May 16, 2026 · 14 MIN

Clinical Conversations: GLP Practice Insights: GLP-1 Receptor Agonist’s Role in Mental Health and Substance Use Disorders (CE)

from ASHPOfficial · host American Society of Health-System Pharmacists©

This podcast is a brief review of emerging literature focusing on the potential use of GLP-1 receptor agonists in the treatment of mental health and substance use disorders. The episode explores how GLP-1 receptor agonists work to alter neurotransmitter systems and impact inflammation in the brain.  The information presented during the podcast reflects solely the opinions of the presenter. The information and materials are not, and are not intended as, a comprehensive source of drug information on this topic. The contents of the podcast have not been reviewed by ASHP, and should neither be interpreted as the official policies of ASHP, nor an endorsement of any product(s), nor should they be considered as a substitute for the professional judgment of the pharmacist or physician.

Episode metadata supplied by the publisher feed · Published May 16, 2026

Embed this episode

NOW PLAYING

Clinical Conversations: GLP Practice Insights: GLP-1 Receptor Agonist’s Role in Mental Health and Substance Use Disorders (CE)

0:00 14:41

No transcript for this episode yet

We transcribe on demand. Request one and we'll notify you when it's ready — usually under 10 minutes.

No similar episodes found.

No similar podcasts found.

Frequently Asked Questions

How long is this episode of ASHPOfficial?

This episode is 14 minutes long.

When was this ASHPOfficial episode published?

This episode was published on May 16, 2026.

Can I download this ASHPOfficial episode?

Yes. Use the download control on the episode player to save the publisher-provided media file.
URL copied to clipboard!